Fenebrutinib (GDC-0853) CAS:1434048-34-6
Fenebrutinib (GDC-0853)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1571 | 50mg | 425.00 | + Add to cart |
|
| R-C-1571 | 100mg | 780.00 | + Add to cart |
|
| R-C-1571 | 200mg | 1230.00 | + Add to cart |
|
|
|
||||
Product description
Fenebrutinib(GDC-0853)is a potent,selective, orally available,and noncovalent bruton is tyrosine kinase(Btk)inhibitor with Kis of 0.91 nM,1.6,1.3,12.6,and 3.4 nM for WT Btk,and the C481S,C481R,T474I,T474M mutants.Fenebrutinib has the potential for rheumatoid arthritis and systemic lupus erythematosus research.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Fenebrutinib (GDC-0853)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


